Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Poster Session II - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION 06.00 - NOVEL TARGET/ EXPERIMENTAL FIDINGS TO CLINICAL TRANSLATION - 06.01 - PATHOPHYSIOLOGY OF STROKE / TRANSLATIONAL MEDICINE P1080 - ESOC25-706 INFLAMMATORY BLOOD CELL COUNTS PREDICT HEMORRHAGIC TRANSFORMATION AND 3-MONTH DISABILITY IN ISCHEMIC STROKE PATIENTS, WITH AND WITHOUT ACUTE REVASCULARIZATION TREATMENTS Julien Mouyal 1 , Patrik Michel 1 , Davide Strambo 1 1 Lausanne University Hospital, Lausanne, Switzerland Background and Aims: The inflammatory response and immune regulation are critical factors for ischemic brain injury
As with other GLP-1 analogs, gastrointestinal (GI) events are the most commonly reported adverse effects with semaglutide
Tracking symptom severity, distribution, and functional impact on a consistent schedule reveals trends that day-to-day subjective impressions would miss
The MHRA has not issued specific warnings about B12 toxicity from supplements, reflecting the vitamin's excellent safety profile in the general population
A narrative review of BPC157 for musculoskeletal healing
